Last reviewed · How we verify
Simvastatin 40mg
At a glance
| Generic name | Simvastatin 40mg |
|---|---|
| Also known as | Zocor, Simvastatin, Brand name: Simvastatin Normon, 40 mg, ATC-code: C10AA01, C10AA01 |
| Sponsor | Marc Goodman |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer (PHASE2)
- Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis (EARLY_PHASE1)
- [Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers] (PHASE1)
- Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer (EARLY_PHASE1)
- Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers (PHASE1)
- Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis (PHASE3)
- Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC (PHASE1)
- A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Simvastatin 40mg CI brief — competitive landscape report
- Simvastatin 40mg updates RSS · CI watch RSS
- Marc Goodman portfolio CI